» Articles » PMID: 22162267

UM-SCC-104: a New Human Papillomavirus-16-positive Cancer Stem Cell-containing Head and Neck Squamous Cell Carcinoma Cell Line

Abstract

Background: Few human papillomavirus (HPV)(+) head and neck squamous cell carcinoma (HNSCC) cell lines exist. We established University of Michigan-squamous cell carcinoma-104 (UM-SCC-104), a new HPV(+) HNSCC cell line from a recurrent oral cavity tumor, and characterized it for the presence of cancer stem cells (CSCs).

Methods: Tumor cells were tested for biomarker expression by immunohistology, and the presence of HPV was assessed by several methods.

Results: UM-SCC-104 has a unique genotype, contains HPV-16, and expresses E6/E7. Inoculation of aldehyde dehydrogenase (ALDH)(+) and ALDH(-) cells in an immunocompromised mouse resulted in tumor growth from the ALDH(+) cells after 6 weeks that recapitulated the histology of the primary, whereas ALDH(-) cells did not produce tumors.

Conclusion: UM-SCC-104, a new HPV-16, CSC-containing HNSCC cell line will aid in studying recurrent HPV(+) tumors. The aggressive nature of this tumor is consistent with high uniform expression of epidermal growth factor receptor (EGFR) and a functionally significant proportion of ALDH(+) CSCs.

Citing Articles

Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses.

James C, Lewis R, Fakunmoju A, Witt A, Youssef A, Wang X J Virol. 2024; 98(10):e0102424.

PMID: 39269177 PMC: 11494926. DOI: 10.1128/jvi.01024-24.


DNA Anchoring Strength Directly Correlates with Spherical Nucleic Acid-Based HPV E7 Cancer Vaccine Potency.

Hwang J, Dittmar J, Kang J, Ocampo T, Evangelopoulos M, Han Z Nano Lett. 2024; 24(25):7629-7636.

PMID: 38874796 PMC: 11540143. DOI: 10.1021/acs.nanolett.4c01392.


Lipid-Coated Polymeric Nanoparticles for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinomas.

Roschenko V, Ayoub A, Engelhardt K, Schafer J, Amin M, Preis E Pharmaceutics. 2023; 15(10).

PMID: 37896172 PMC: 10610306. DOI: 10.3390/pharmaceutics15102412.


IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism.

Hill B, Calder A, Flemming J, Guo Y, Gilmore S, Trofa M Mol Carcinog. 2023; 62(9):1428-1443.

PMID: 37401875 PMC: 10524928. DOI: 10.1002/mc.23587.


Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods.

Li D, Thomas C, Shrivastava N, Gersten A, Gadsden N, Schlecht N J Med Virol. 2022; 95(2):e28388.

PMID: 36477880 PMC: 10168123. DOI: 10.1002/jmv.28388.


References
1.
Maxwell J, Kumar B, Feng F, Worden F, Lee J, Eisbruch A . Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res. 2010; 16(4):1226-35. PMC: 2822887. DOI: 10.1158/1078-0432.CCR-09-2350. View

2.
Gillison M, DSouza G, Westra W, Sugar E, Xiao W, Begum S . Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008; 100(6):407-20. DOI: 10.1093/jnci/djn025. View

3.
Ginestier C, Liu S, Diebel M, Korkaya H, Luo M, Brown M . CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest. 2010; 120(2):485-97. PMC: 2810075. DOI: 10.1172/JCI39397. View

4.
Kim S, Chu K, Lee H, Lee K, Carey T . Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol. 1997; 117(5):775-84. DOI: 10.3109/00016489709113477. View

5.
Yang H, Yang K, Khafagi A, Tang Y, Carey T, Opipari A . Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc Natl Acad Sci U S A. 2005; 102(21):7683-8. PMC: 1140403. DOI: 10.1073/pnas.0406904102. View